Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Shares withheld for taxes Niedzwiecki Daniel gave up 243 shares (to pay taxes)
  2. 4 Open-market sale President & CEO sold 15,580 shares at $25.83 ($402,369)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Operations Officer sold 2,253 shares at $24.37 ($54,912)
  5. 4 Open-market sale Chief Business Officer sold 7,435 shares at $24.60 ($182,901)
  6. 4 Grant or award Niedzwiecki Daniel acquired 9,093 shares (grant or award)
  7. 4 Grant or award Director acquired 8,513 shares (grant or award)
  8. 4 Grant or award Director acquired 8,513 shares (grant or award)
  9. 4 Grant or award Director acquired 8,513 shares (grant or award)
  10. 4 Grant or award Director acquired 8,513 shares (grant or award)
  11. 4 Grant or award Director acquired 8,513 shares (grant or award)
  12. 4 Grant or award Director acquired 8,513 shares (grant or award)
  13. 4 Grant or award Director acquired 8,513 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 1,139 shares (grant or award)
  18. 4 Open-market sale SVP and General Counsel sold 7,500 shares at $21.75 ($163,125)
  19. 4 Open-market sale President & CEO sold 19,421 shares at $20.66 ($401,277)
  20. 4 Open-market sale Director sold 2,800 shares at $21.22 ($59,416)

Page 15 of 30 · 599 filings